Retrieve available abstracts of 6 articles: HTML format
Single Articles
October 2025
FU Z, Li S, Xue J, Li Q, et al A potential therapeutic target at Connexin 43 serine phosphorylation against
ischaemia/reperfusion arrhythmia.
Br J Pharmacol. 2025;182:4516-4534. PubMedAbstract available
September 2025
HEITMANN S, Vandenberg JI, Hill AP Independent derivations of the axis of arrhythmia for predicting drug-induced
torsades de pointes.
Br J Pharmacol. 2025;182:4299-4313. PubMedAbstract available
March 2025
HINIESTO-INIGO I, Sridhar A, Louradour J, Cruz A, et al Rescue of loss-of-function long QT syndrome-associated mutations in K(V)7.1/KCNE1
by the endocannabinoid N-arachidonoyl-L-serine (ARA-S).
Br J Pharmacol. 2025 Mar 14. doi: 10.1111/bph.70008. PubMedAbstract available
June 2024
NISKALA A, Heijman J, Dobrev D, Jespersen T, et al Targeting the NLRP3 inflammasome signalling for the management of atrial
fibrillation.
Br J Pharmacol. 2024 Jun 15. doi: 10.1111/bph.16470. PubMedAbstract available
April 2024
LEI CL, Whittaker DG, Mirams GR The impact of uncertainty in hERG binding mechanism on in silico predictions of
drug-induced proarrhythmic risk.
Br J Pharmacol. 2024;181:987-1004. PubMedAbstract available
February 2024
CHEN IS, Yasuda J, Notomi T, Nakamura TY, et al Licorice metabolite 18beta-glycyrrhetinic acid activates G protein-gated inwardly
rectifying K(+) channels.
Br J Pharmacol. 2024;181:447-463. PubMedAbstract available